Novugen Company Profile
✉ Email this page to a colleague
What is the competitive landscape for NOVUGEN, and what generic and branded alternatives to NOVUGEN drugs are available?
NOVUGEN has five approved drugs.
Summary for Novugen
US Patents: | 0 |
Tradenames: | 5 |
Ingredients: | 5 |
NDAs: | 5 |
Patent Litigation for Novugen: | See patent lawsuits for Novugen |
Drugs and US Patents for Novugen
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novugen | MIDODRINE HYDROCHLORIDE | midodrine hydrochloride | TABLET;ORAL | 211973-002 | Oct 17, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Novugen | MIDODRINE HYDROCHLORIDE | midodrine hydrochloride | TABLET;ORAL | 211973-001 | Oct 17, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Novugen | LENALIDOMIDE | lenalidomide | CAPSULE;ORAL | 217281-006 | Sep 11, 2024 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Novugen | ABIRATERONE ACETATE | abiraterone acetate | TABLET;ORAL | 215947-002 | Jan 5, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Novugen | LENALIDOMIDE | lenalidomide | CAPSULE;ORAL | 217281-002 | Sep 11, 2024 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Novugen | LENALIDOMIDE | lenalidomide | CAPSULE;ORAL | 217281-003 | Sep 11, 2024 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Novugen | TRAMETINIB DIMETHYL SULFOXIDE | trametinib dimethyl sulfoxide | TABLET;ORAL | 219002-001 | Aug 6, 2024 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.